Chris can you comment on this..??
It it as bad as it reads..??
Three years ago, a former Cephalon manager filed a whisteblower lawsuit over alleged illegal marketing of two drugs – the Treanda treatment for chronic lymphocytic leukemia and the Fentora painkiller – prompting the US Attorney in New York to open an investigation into the drugmaker, which is now owned by Teva Pharmaceutical (TEVA).
Now, though, further details are emerging about the extent to which Cephalon executives allegedly conspired to use questionable studies and off-label marketing tactics to boost sales of Treanda, in particular. The allegations, which were made by a former Cephalon employee listed as 'John Doe,’ cite familiar-sounding shenanigans, but an executive strategy session sheds new light on the effort.
Here is the background: Cephalon sought to promote Treanda for an unapproved use - in this case, front-line treatment for indolent, or slowly progressing, non-Hodgkin's lymphoma, according to the lawsuit. The medication was only approved for CLL and second or third-line iNHL. But in 2008, Cephalon executives were nervous that marketing exclusivity tied to orphan drug status would expire in 2015.
A Cephalon vp arranged for waiters to burst into a 2008 launch meeting carrying trays of $50 bills and, as they circulated throughout the room, the drug reps were encouraged to grab fistfuls of money. As they did so, the Cephalon vp told the sales force that promoting Treanda would be like “taking free money.” This was just a few months before the settlement with the feds.
Pharmalive.com - Thu, 06/20/2013 - 10:58am by Ed Silverman
To read the remainder of this article, go to Pharmalot. pharmalive.com/how-to-motiv...
[Edited by CLLSA/Admin 12:32 - 22/06/32 to remove duplicate passage and insert the reference link to the quoted snippets from the article., this gives access to the rest of the story and links it provides to the latest version of the lawsuit and further information.- allowing those who choose to reach it.]
when to begin treatment
Insane Drug Prices 
New treatments for coronavirus 
